WebThe latest price target for . Dyne Therapeutics (NASDAQ: DYN) was reported by Chardan Capital on March 3, 2024.The analyst firm set a price target for $20.00 expecting DYN to rise to within 12 ... WebHere's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now Zacks - Fri Dec 9, 2024 . Dyne Therapeutics, Inc. (DYN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement...
Investors & Media Dyne Therapeutics, Inc.
WebComplete Dyne Therapeutics Inc. stock information by Barron's. View real-time DYN stock price and news, along with industry-best analysis. WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a ... dgl.heterograph metapath
Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus …
WebMar 29, 2024 · Here's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now. Dyne Therapeutics, Inc. (DYN) appears to have found support after losing … WebSep 6, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to … WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 after opening rate of $9.34 while the lowest price it went was recorded $8.77 before closing at $9.38.Recently in News on March 23, 2024, Dyne Therapeutics Receives FDA … dglheterograph\\u0027 object has no attribute cuda